262 related articles for article (PubMed ID: 30694600)
1. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: A literature review.
Møller Gundersen K; Nygaard Jensen J; Bjerrum L; Hansen MP
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):550-559. PubMed ID: 30694600
[TBL] [Abstract][Full Text] [Related]
2. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.
López-Alcalde J; Rodriguez-Barrientos R; Redondo-Sánchez J; Muñoz-Gutiérrez J; Molero García JM; Rodríguez-Fernández C; Heras-Mosteiro J; Marin-Cañada J; Casanova-Colominas J; Azcoaga-Lorenzo A; Hernandez Santiago V; Gómez-García M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD009070. PubMed ID: 30188565
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.
Li JZ; Winston LG; Moore DH; Bent S
Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048
[TBL] [Abstract][Full Text] [Related]
4. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
Haider BA; Saeed MA; Bhutta ZA
Cochrane Database Syst Rev; 2008 Apr; (2):CD005976. PubMed ID: 18425930
[TBL] [Abstract][Full Text] [Related]
5. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics for community acquired pneumonia in adult outpatients.
Bjerre LM; Verheij TJ; Kochen MM
Cochrane Database Syst Rev; 2004; (2):CD002109. PubMed ID: 15106168
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults.
Tansarli GS; Mylonakis E
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987137
[TBL] [Abstract][Full Text] [Related]
8. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.
Lassi ZS; Imdad A; Bhutta ZA
Cochrane Database Syst Rev; 2015 Jun; (6):CD008032. PubMed ID: 26077639
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for community acquired pneumonia in adult outpatients.
Bjerre LM; Verheij TJ; Kochen MM
Cochrane Database Syst Rev; 2009 Oct; (4):CD002109. PubMed ID: 19821292
[TBL] [Abstract][Full Text] [Related]
10. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.
Li Q; Zhou Q; Florez ID; Mathew JL; Shang L; Zhang G; Tian X; Fu Z; Liu E; Luo Z; Chen Y
JAMA Pediatr; 2022 Dec; 176(12):1199-1207. PubMed ID: 36374480
[TBL] [Abstract][Full Text] [Related]
11. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
Zhang L; Wang R; Falagas ME; Chen LA; Liu YN
Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
[TBL] [Abstract][Full Text] [Related]
12. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
13. [Short course antibiotic treatment during community acquired pneumonia: Review of the literature and perspectives].
Philippot Q; Dinh A; Voiriot G
Rev Mal Respir; 2020 Jan; 37(1):26-33. PubMed ID: 31883818
[TBL] [Abstract][Full Text] [Related]
14. How to reduce antibiotic consumption for community-acquired pneumonia?
Montassier E; Goffinet N; Potel G; Batard E
Med Mal Infect; 2013 Feb; 43(2):52-9. PubMed ID: 23433607
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia.
Pettigrew MM; Kwon J; Gent JF; Kong Y; Wade M; Williams DJ; Creech CB; Evans S; Pan Q; Walter EB; Martin JM; Gerber JS; Newland JG; Hofto ME; Staat MA; Fowler VG; Chambers HF; Huskins WC;
mBio; 2022 Apr; 13(2):e0019522. PubMed ID: 35323040
[TBL] [Abstract][Full Text] [Related]
16. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
Robenshtok E; Shefet D; Gafter-Gvili A; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2008 Jan; (1):CD004418. PubMed ID: 18254049
[TBL] [Abstract][Full Text] [Related]
17. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
[TBL] [Abstract][Full Text] [Related]
18. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.
Kyriakidou KG; Rafailidis P; Matthaiou DK; Athanasiou S; Falagas ME
Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841
[TBL] [Abstract][Full Text] [Related]
19. Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials.
Hanretty AM; Gallagher JC
Pharmacotherapy; 2018 Jun; 38(6):674-687. PubMed ID: 29679383
[TBL] [Abstract][Full Text] [Related]
20. Advances in antibiotic therapy for community-acquired pneumonia.
Viasus D; Garcia-Vidal C; Carratalà J
Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
